About Darlene
My journey began in preclinical research at Yale University and progressed through key leadership roles at industry innovators such as Regeneron, ImClone, and Eli Lilly. Over the years, I've partnered with leading pharmaceutical and biotech organizations — including Syneos, VaxInnate, BMS, Merck, and Advaxis — shaping and accelerating clinical strategies across global markets.
From the research bench to the executive suite, my mission has remained constant: to bring transformative therapies to patients — faster, smarter, and with lasting impact.
Along the way, I've contributed to respected scientific publications and earned an MBA in Business Leadership, enabling me to bridge the gap between science and strategy to deliver measurable results.
Our Mission
In the biopharmaceutical world, groundbreaking academic research often sparks the development of transformative investigational therapies. Yet, smaller organizations frequently face operational hurdles that slow progress — from inefficient systems to resource constraints and missed strategic opportunities.
At Consult with Darlene, we close that gap.
We empower emerging biopharma and research-driven organizations to streamline clinical operations, optimize workflows, and bring therapies to patients faster. By integrating the latest advancements in AI, digital systems, and data-driven strategy, we help teams move with clarity, speed, and confidence. Our approach is rooted in scientific rigor and business excellence — enabling innovation to flourish and impact to scale.
We engage directly with clients to uncover insights that traditional consultancies often miss. Every recommendation is custom-built to maximize impact and long-term efficiency.
We deliver the strategic precision of McKinsey & Company — with deeper biotech and pharma specialization and a more personal, collaborative approach.
With international experience, we understand the regulatory and cultural nuances that define success in diverse markets.
With international experience, we understand the regulatory and cultural nuances that define success in diverse markets.
If you're ready to accelerate your path to market and bring your innovations to patients faster, let's talk.
Consult with Darlene is more than a consultancy — it's your strategic partner in transforming vision into measurable success.
Get in TouchBook a 30-minute consultation with Darlene